NCT07119190View on ClinicalTrials.gov

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

Not yet recruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

October 30, 2027

Conditions
Non-Small Cell Lung Cancer
All Listed Sponsors
collaborator

Beijing Municipal Health Commission

OTHER_GOV

lead

Peking University People's Hospital

OTHER